Both in Pharmaceuticals
Immunome vs Nurix Therapeutics
Over the past year IMNM returned +93.0% and NRIX returned +155.1%; their daily moves had a correlation of 0.45.
IMNM +93.0% NRIX +155.1%Growth of $1, one year, split-adjusted
| Metric | IMNM | NRIX |
|---|---|---|
| Price | $21.89 | $23.68 |
| Market cap | $2.49B | $2.46B |
| Today | +0.97% | +0.02% |
| 1 month | −20.6% | −9.7% |
| 6 months | +13.4% | +61.4% |
| Year to date | +1.9% | +24.8% |
| 1 year | +88.9% | +165.1% |
| Revenue growth (YoY) | −100.0% | −79.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −990.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 66.8× |
| Net cash | $520.0M | $443.5M |
| Dividend yield | — | — |
| Volatility (60d) | 50.6% | 36.6% |
| Short % of float | 16.1% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).